Evolent Health Inc（EVH）の株式分析EVHEvolent Health Inc

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers primary solutions, including specialty care management services and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner. It operates in the Healthcare sector (SERVICES-MANAGEMENT SERVICES industry).

Evolent Health Inc is a good buy right now, as it is currently priced at $4.04 with a 5-day change of +16.76%, indicating positive momentum. The forward P/E ratio is 8.62, suggesting it is undervalued compared to its earnings potential. However, the main risk is its high net debt-to-EBITDA ratio of 7x, which could lead to challenges in raising capital if market conditions worsen.

13 analysts cover EVH: 13 rate it Buy, 0 Hold and 0 Sell. The average price target is 9.33.